ID   CASPE_HUMAN             Reviewed;         242 AA.
AC   P31944; O95823; Q3SYC9;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2001, sequence version 2.
DT   18-JUN-2025, entry version 209.
DE   RecName: Full=Caspase-14;
DE            Short=CASP-14;
DE            EC=3.4.22.-;
DE   Contains:
DE     RecName: Full=Caspase-14 subunit p17, mature form;
DE   Contains:
DE     RecName: Full=Caspase-14 subunit p10, mature form;
DE   Contains:
DE     RecName: Full=Caspase-14 subunit p20, intermediate form;
DE   Contains:
DE     RecName: Full=Caspase-14 subunit p8, intermediate form;
DE   Flags: Precursor;
GN   Name=CASP14;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11062009; DOI=10.1006/bbrc.2000.3698;
RA   Eckhart L., Ban J., Fischer H., Tschachler E.;
RT   "Caspase-14: analysis of gene structure and mRNA expression during
RT   keratinocyte differentiation.";
RL   Biochem. Biophys. Res. Commun. 277:655-659(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=12181750; DOI=10.1038/sj.cdd.4401061;
RA   Pistritto G., Jost M., Srinivasula S.M., Baffa R., Poyet J.-L., Kari C.,
RA   Lazebnik Y., Rodeck U., Alnemri E.S.;
RT   "Expression and transcriptional regulation of caspase-14 in simple and
RT   complex epithelia.";
RL   Cell Death Differ. 9:995-1006(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 68-74; 137-147 AND 154-162.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel protein
RT   database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [5]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=11175259; DOI=10.1038/sj.cdd.4400785;
RA   Lippens S., Kockx M., Knaapen M., Mortier L., Polakowska R., Verheyen A.,
RA   Garmyn M., Zwijsen A., Formstecher P., Huylebroeck D., Vandenabeele P.,
RA   Declercq W.;
RT   "Epidermal differentiation does not involve the pro-apoptotic executioner
RT   caspases, but is associated with caspase-14 induction and processing.";
RL   Cell Death Differ. 7:1218-1224(2000).
RN   [6]
RP   PROTEIN SEQUENCE OF 153-163, PROTEOLYTIC PROCESSING, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=12200134; DOI=10.1016/s0006-291x(02)02015-6;
RA   Chien A.J., Presland R.B., Kuechle M.K.;
RT   "Processing of native caspase-14 occurs at an atypical cleavage site in
RT   normal epidermal differentiation.";
RL   Biochem. Biophys. Res. Commun. 296:911-917(2002).
RN   [7]
RP   FUNCTION.
RX   PubMed=15301553; DOI=10.1021/bi0498048;
RA   Mikolajczyk J., Scott F.L., Krajewski S., Sutherlin D.P., Salvesen G.S.;
RT   "Activation and substrate specificity of caspase-14.";
RL   Biochemistry 43:10560-10569(2004).
RN   [8]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15556625; DOI=10.1016/j.febslet.2004.10.046;
RA   Fischer H., Stichenwirth M., Dockal M., Ghannadan M., Buchberger M.,
RA   Bach J., Kapetanopoulos A., Declercq W., Tschachler E., Eckhart L.;
RT   "Stratum corneum-derived caspase-14 is catalytically active.";
RL   FEBS Lett. 577:446-450(2004).
RN   [9]
RP   FUNCTION.
RX   PubMed=16854378; DOI=10.1016/j.bbrc.2006.06.156;
RA   Park K., Kuechle M.K., Choe Y., Craik C.S., Lawrence O.T., Presland R.B.;
RT   "Expression and characterization of constitutively active human
RT   caspase-14.";
RL   Biochem. Biophys. Res. Commun. 347:941-948(2006).
RN   [10]
RP   PROTEOLYTIC PROCESSING, SUBUNIT, ACTIVITY REGULATION, AND FUNCTION.
RX   PubMed=19960512; DOI=10.1002/jcb.22425;
RA   Hibino T., Fujita E., Tsuji Y., Nakanishi J., Iwaki H., Katagiri C.,
RA   Momoi T.;
RT   "Purification and characterization of active caspase-14 from human
RT   epidermis and development of the cleavage site-directed antibody.";
RL   J. Cell. Biochem. 109:487-497(2010).
RN   [11]
RP   PROTEOLYTIC PROCESSING, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, SUBUNIT,
RP   AND FUNCTION.
RX   PubMed=22825846; DOI=10.1074/jbc.m112.357467;
RA   Yamamoto M., Miyai M., Matsumoto Y., Tsuboi R., Hibino T.;
RT   "Kallikrein-related peptidase-7 regulates caspase-14 maturation during
RT   keratinocyte terminal differentiation by generating an intermediate form.";
RL   J. Biol. Chem. 287:32825-32834(2012).
RN   [12]
RP   INDUCTION, AND FUNCTION.
RX   PubMed=25121097; DOI=10.1155/2014/417986;
RA   Beasley S., El-Sherbiny M., Megyerdi S., El-Shafey S., Choksi K.,
RA   Kaddour-Djebbar I., Sheibani N., Hsu S., Al-Shabrawey M.;
RT   "Caspase-14 expression impairs retinal pigment epithelium barrier function:
RT   potential role in diabetic macular edema.";
RL   Biomed. Res. Int. 2014:417986-417986(2014).
RN   [13]
RP   FUNCTION.
RX   PubMed=24743736; DOI=10.1038/cddis.2014.145;
RA   Yamamoto-Tanaka M., Makino T., Motoyama A., Miyai M., Tsuboi R., Hibino T.;
RT   "Multiple pathways are involved in DNA degradation during keratinocyte
RT   terminal differentiation.";
RL   Cell Death Dis. 5:E1181-E1181(2014).
RN   [14]
RP   INVOLVEMENT IN ARCI12.
RX   PubMed=27494380; DOI=10.2340/00015555-2510;
RA   Kirchmeier P., Zimmer A., Bouadjar B., Roesler B., Fischer J.;
RT   "Whole-Exome-Sequencing reveals small deletions in CASP14 in patients with
RT   autosomal recessive inherited ichthyosis.";
RL   Acta Derm. Venereol. 96:102-104(2017).
CC   -!- FUNCTION: Non-apoptotic caspase involved in epidermal differentiation.
CC       Is the predominant caspase in epidermal stratum corneum
CC       (PubMed:15556625). Seems to play a role in keratinocyte differentiation
CC       and is required for cornification. Regulates maturation of the
CC       epidermis by proteolytically processing filaggrin (By similarity). In
CC       vitro has a preference for the substrate [WY]-X-X-D motif and is active
CC       on the synthetic caspase substrate WEHD-ACF (PubMed:16854378,
CC       PubMed:19960512). Involved in processing of prosaposin in the epidermis
CC       (By similarity). May be involved in retinal pigment epithelium cell
CC       barrier function (PubMed:25121097). Involved in DNA degradation in
CC       differentiated keratinocytes probably by cleaving DFFA/ICAD leading to
CC       liberation of DFFB/CAD (PubMed:24743736).
CC       {ECO:0000250|UniProtKB:O89094, ECO:0000269|PubMed:15301553,
CC       ECO:0000269|PubMed:15556625, ECO:0000269|PubMed:16854378,
CC       ECO:0000269|PubMed:19960512, ECO:0000269|PubMed:22825846,
CC       ECO:0000269|PubMed:24743736, ECO:0000305|PubMed:25121097}.
CC   -!- ACTIVITY REGULATION: Inhibited by caspase-1 inhibitor YVAD-FMK and the
CC       pan-caspase inhibitor VAD-FMK. {ECO:0000269|PubMed:19960512}.
CC   -!- SUBUNIT: Heterodimer of a large and a small subunit, both processed
CC       from the precursor; the mature active form is a p17/p10 dimer and the
CC       intermediate form a p20/p8 dimer. {ECO:0000269|PubMed:12200134,
CC       ECO:0000269|PubMed:19960512, ECO:0000269|PubMed:22825846}.
CC   -!- INTERACTION:
CC       P31944; P50222: MEOX2; NbExp=3; IntAct=EBI-2510738, EBI-748397;
CC       P31944; P07602: PSAP; NbExp=3; IntAct=EBI-2510738, EBI-716699;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11175259,
CC       ECO:0000269|PubMed:12200134, ECO:0000269|PubMed:22825846}. Nucleus
CC       {ECO:0000269|PubMed:11175259}.
CC   -!- TISSUE SPECIFICITY: Expressed in keratinocytes of adult skin suprabasal
CC       layers (from spinous layers to the stratum granulosum and stratum
CC       corneum) (at protein level). Expressed in keratinocytes of hair shaft
CC       and sebaceous glands (at protein level). In psoriatic skin only
CC       expressed at very low levels (PubMed:11175259). The p17/10 mature form
CC       is expressed in epidermis stratum corneum, the p20/p8 intermediate form
CC       in epidermis upper granular cells of the stratum granulosum
CC       (PubMed:22825846). {ECO:0000269|PubMed:11175259,
CC       ECO:0000269|PubMed:15556625, ECO:0000269|PubMed:22825846}.
CC   -!- INDUCTION: In undifferentiated keratinocytes under postconfluency
CC       growth conditions (in vitro) (PubMed:11175259). By high glucose in
CC       retinal pigment epithelia cells (PubMed:25121097).
CC       {ECO:0000269|PubMed:11175259, ECO:0000269|PubMed:25121097}.
CC   -!- PTM: Maturation by proteolytic processing appears to be a two-step
CC       process. The precursor is processed by KLK7 to yield the p20/p8
CC       intermediate form which acts on the precursor to yield the p17/p10
CC       mature form (PubMed:22825846). Initially, cleavage between Ile-152 and
CC       Lys-153 has been proposed to yield the large and small subunits of the
CC       active enzyme (PubMed:12200134). {ECO:0000269|PubMed:19960512,
CC       ECO:0000269|PubMed:22825846, ECO:0000305|PubMed:12200134}.
CC   -!- DISEASE: Ichthyosis, congenital, autosomal recessive 12 (ARCI12)
CC       [MIM:617320]: A form of autosomal recessive congenital ichthyosis, a
CC       disorder of keratinization with abnormal differentiation and
CC       desquamation of the epidermis, resulting in abnormal skin scaling over
CC       the whole body. The main skin phenotypes are lamellar ichthyosis (LI)
CC       and non-bullous congenital ichthyosiform erythroderma (NCIE), although
CC       phenotypic overlap within the same patient or among patients from the
CC       same family can occur. Lamellar ichthyosis is a condition often
CC       associated with an embedment in a collodion-like membrane at birth;
CC       skin scales later develop, covering the entire body surface. Non-
CC       bullous congenital ichthyosiform erythroderma characterized by fine
CC       whitish scaling on an erythrodermal background; larger brownish scales
CC       are present on the buttocks, neck and legs.
CC       {ECO:0000269|PubMed:27494380}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Expressed in bacteria requires high concentrations of
CC       kosmotropic salts to be activated (PubMed:15301553). The mature and the
CC       intermediate form differ in activity towards synthetic caspase
CC       substrates: the p17/p10 mature form but not the p20/p8 intermediate
CC       form is active on WEHD-MCA; p20/p8 is active on a number of other
CC       caspase substrates without any marked preference (VEID-AFC, DEVD-AFC,
CC       LEVD-AFC and LEHD-AFC) (PubMed:22825846). {ECO:0000269|PubMed:15301553,
CC       ECO:0000269|PubMed:22825846}.
CC   -!- SIMILARITY: Belongs to the peptidase C14A family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF097874; AAD16173.1; -; mRNA.
DR   EMBL; BC069541; AAH69541.1; -; mRNA.
DR   EMBL; BC103868; AAI03869.1; -; mRNA.
DR   EMBL; BC103869; AAI03870.1; -; mRNA.
DR   CCDS; CCDS12323.1; -.
DR   PIR; JC7517; JC7517.
DR   RefSeq; NP_036246.1; NM_012114.3.
DR   AlphaFoldDB; P31944; -.
DR   SMR; P31944; -.
DR   BioGRID; 117116; 207.
DR   FunCoup; P31944; 180.
DR   IntAct; P31944; 87.
DR   MINT; P31944; -.
DR   STRING; 9606.ENSP00000393417; -.
DR   BindingDB; P31944; -.
DR   ChEMBL; CHEMBL5991; -.
DR   GuidetoPHARMACOLOGY; 1627; -.
DR   MEROPS; C14.018; -.
DR   GlyGen; P31944; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P31944; -.
DR   PhosphoSitePlus; P31944; -.
DR   BioMuta; CASP14; -.
DR   DMDM; 12231007; -.
DR   jPOST; P31944; -.
DR   MassIVE; P31944; -.
DR   PaxDb; 9606-ENSP00000393417; -.
DR   PeptideAtlas; P31944; -.
DR   ProteomicsDB; 54815; -.
DR   TopDownProteomics; P31944; -.
DR   Antibodypedia; 4107; 483 antibodies from 45 providers.
DR   DNASU; 23581; -.
DR   Ensembl; ENST00000427043.4; ENSP00000393417.2; ENSG00000105141.6.
DR   GeneID; 23581; -.
DR   KEGG; hsa:23581; -.
DR   MANE-Select; ENST00000427043.4; ENSP00000393417.2; NM_012114.3; NP_036246.1.
DR   UCSC; uc010dzv.3; human.
DR   AGR; HGNC:1502; -.
DR   CTD; 23581; -.
DR   DisGeNET; 23581; -.
DR   GeneCards; CASP14; -.
DR   GeneReviews; CASP14; -.
DR   HGNC; HGNC:1502; CASP14.
DR   HPA; ENSG00000105141; Tissue enriched (skin).
DR   MalaCards; CASP14; -.
DR   MIM; 605848; gene.
DR   MIM; 617320; phenotype.
DR   OpenTargets; ENSG00000105141; -.
DR   VEuPathDB; HostDB:ENSG00000105141; -.
DR   eggNOG; KOG3573; Eukaryota.
DR   GeneTree; ENSGT00940000162117; -.
DR   HOGENOM; CLU_036904_2_2_1; -.
DR   InParanoid; P31944; -.
DR   OMA; REDPVSC; -.
DR   OrthoDB; 6044770at2759; -.
DR   PAN-GO; P31944; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; P31944; -.
DR   BioCyc; MetaCyc:ENSG00000105141-MONOMER; -.
DR   PathwayCommons; P31944; -.
DR   Reactome; R-HSA-6809371; Formation of the cornified envelope.
DR   Reactome; R-HSA-9725554; Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin.
DR   SignaLink; P31944; -.
DR   BioGRID-ORCS; 23581; 13 hits in 1150 CRISPR screens.
DR   ChiTaRS; CASP14; human.
DR   GeneWiki; Caspase_14; -.
DR   GenomeRNAi; 23581; -.
DR   Pharos; P31944; Tchem.
DR   PRO; PR:P31944; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P31944; protein.
DR   Bgee; ENSG00000105141; Expressed in skin of abdomen and 77 other cell types or tissues.
DR   ExpressionAtlas; P31944; baseline and differential.
DR   GO; GO:0001533; C:cornified envelope; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:CACAO.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0045095; C:keratin filament; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:CACAO.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; TAS:ProtInc.
DR   GO; GO:0070268; P:cornification; TAS:UniProtKB.
DR   GO; GO:0008544; P:epidermis development; TAS:ProtInc.
DR   GO; GO:0031424; P:keratinization; TAS:UniProtKB.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IBA:GO_Central.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   CDD; cd00032; CASc; 1.
DR   FunFam; 3.40.50.1460:FF:000015; Caspase 14; 1.
DR   Gene3D; 3.40.50.1460; -; 1.
DR   InterPro; IPR029030; Caspase-like_dom_sf.
DR   InterPro; IPR033139; Caspase_cys_AS.
DR   InterPro; IPR002398; Pept_C14.
DR   InterPro; IPR011600; Pept_C14_caspase.
DR   InterPro; IPR002138; Pept_C14_p10.
DR   InterPro; IPR001309; Pept_C14_p20.
DR   InterPro; IPR015917; Pept_C14A.
DR   PANTHER; PTHR10454; CASPASE; 1.
DR   PANTHER; PTHR10454:SF131; CASPASE-14; 1.
DR   Pfam; PF00656; Peptidase_C14; 1.
DR   PRINTS; PR00376; IL1BCENZYME.
DR   SMART; SM00115; CASc; 1.
DR   SUPFAM; SSF52129; Caspase-like; 1.
DR   PROSITE; PS01122; CASPASE_CYS; 1.
DR   PROSITE; PS50207; CASPASE_P10; 1.
DR   PROSITE; PS50208; CASPASE_P20; 1.
DR   neXtProt; NX_P31944; -.
DR   PharmGKB; PA26085; -.
DR   TreeFam; TF102023; -.
PE   1: Evidence at protein level;
KW   Cytoplasm; Differentiation; Direct protein sequencing; Hydrolase;
KW   Ichthyosis; Nucleus; Protease; Proteomics identification;
KW   Reference proteome; Thiol protease; Zymogen.
FT   CHAIN           1..178
FT                   /note="Caspase-14 subunit p20, intermediate form"
FT                   /id="PRO_0000432793"
FT   PROPEP          1..5
FT                   /evidence="ECO:0000269|PubMed:19960512"
FT                   /id="PRO_0000004652"
FT   CHAIN           6..146
FT                   /note="Caspase-14 subunit p17, mature form"
FT                   /id="PRO_0000432794"
FT   PROPEP          147..152
FT                   /evidence="ECO:0000269|PubMed:19960512"
FT                   /id="PRO_0000432795"
FT   CHAIN           153..242
FT                   /note="Caspase-14 subunit p10, mature form"
FT                   /id="PRO_0000004654"
FT   CHAIN           179..242
FT                   /note="Caspase-14 subunit p8, intermediate form"
FT                   /id="PRO_0000432796"
FT   ACT_SITE        89
FT                   /evidence="ECO:0000250|UniProtKB:P29466"
FT   ACT_SITE        132
FT                   /evidence="ECO:0000250|UniProtKB:P29466"
SQ   SEQUENCE   242 AA;  27680 MW;  E539FB7E8DD808A2 CRC64;
     MSNPRSLEEE KYDMSGARLA LILCVTKARE GSEEDLDALE HMFRQLRFES TMKRDPTAEQ
     FQEELEKFQQ AIDSREDPVS CAFVVLMAHG REGFLKGEDG EMVKLENLFE ALNNKNCQAL
     RAKPKVYIIQ ACRGEQRDPG ETVGGDEIVM VIKDSPQTIP TYTDALHVYS TVEGYIAYRH
     DQKGSCFIQT LVDVFTKRKG HILELLTEVT RRMAEAELVQ EGKARKTNPE IQSTLRKRLY
     LQ
//
